With biologic drugs becoming more prominent in the marketplace, protein engineers are now turning their attention to new indications, improved targeting, new formats and products that are truly differentiated relative to competitors. The Antibody Optimization & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics.
Recombinant Protein Therapeutics
Enhancing Antibody Binding and Specificity
Emerging Technologies for Antibody Discovery and Engineering